Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
BMC Cancer|February 13, 2024
Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)Kathryn E Hitchcock, Eric D Miller, Qian Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 29, 2024
Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRCChristina Wu, Reetesh K Pai, Heidi Kosiorek, et al.
Cancer|April 25, 2019
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancerThomas J George, Aaron J Franke, A Bapsi Chakravarthy, et al.
British Journal of Cancer|July 25, 2020
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinomaR Donald Harvey, Bradley C Carthon, Colleen Lewis, et al.
BMC Cancer|August 30, 2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapyMehmet Asim Bilen, Julie M Shabto, Dylan J Martini, et al.
Virchows Archiv : an International Journal of Pathology|October 8, 2025
Utility of quantitative pathologic analysis of pT1 colorectal carcinomas to improve prediction of lymph node metastasisPriya Nayak, Heidi Kosiorek, Reetesh K Pai, et al.
The Lancet. Oncology|May 4, 2023
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 studyJohn H Strickler, Andrea Cercek, Salvatore Siena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid TumorsTaofeek K Owonikoko, R Donald Harvey, Bradley Carthon, et al.
Nature Communications|January 12, 2026
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysisJohn H Strickler, Andrea Cercek, Salvatore Siena, et al.
Cancer Research Communications|May 6, 2024
Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer RecurrenceFrank A Sinicrope, Garth D Nelson, Bahar Saberzadeh-Ardestani, et al.
Pageof 14